Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. They are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease, advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. The company's mission is to deliver functional improvement for individuals, families, and communities. The Principal Scientist, Toxicology is a key member of preclinical development teams, responsible for strategic planning and execution of nonclinical safety plans for Dyne’s portfolio programs. This role supports late discovery through first-in-human and proof-of-concept clinical studies of investigational antibody oligonucleotide therapeutics to treat serious muscle diseases. The Principal Scientist applies an in-depth understanding of regulatory guidance related to nonclinical development, designs, oversees, and critically evaluates exploratory and GLP-compliant toxicology studies. The role also involves authoring and reviewing nonclinical regulatory documents and participating in interactions with regulatory authorities. This is a full-time position based in Waltham, MA.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees